Tudor Investment Corp ET AL lowered its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 55.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,900 shares of the company’s stock after selling 6,200 shares during the period. Tudor Investment Corp ET AL’s holdings in Nu Skin Enterprises were worth $272,000 as of its most recent filing with the SEC.

Several other large investors have also recently added to or reduced their stakes in the stock. BlackRock Inc. increased its stake in Nu Skin Enterprises by 21,593.4% in the first quarter. BlackRock Inc. now owns 6,683,531 shares of the company’s stock valued at $371,201,000 after buying an additional 6,652,722 shares during the period. Vanguard Group Inc. increased its stake in Nu Skin Enterprises by 11.8% in the first quarter. Vanguard Group Inc. now owns 6,011,632 shares of the company’s stock valued at $333,887,000 after buying an additional 634,951 shares during the period. Wellington Management Group LLP increased its stake in Nu Skin Enterprises by 7.3% in the first quarter. Wellington Management Group LLP now owns 1,944,383 shares of the company’s stock valued at $107,991,000 after buying an additional 131,493 shares during the period. Schroder Investment Management Group increased its stake in Nu Skin Enterprises by 139.4% in the first quarter. Schroder Investment Management Group now owns 1,711,619 shares of the company’s stock valued at $94,687,000 after buying an additional 996,731 shares during the period. Finally, State Street Corp increased its stake in Nu Skin Enterprises by 76.7% in the first quarter. State Street Corp now owns 1,416,873 shares of the company’s stock valued at $78,695,000 after buying an additional 614,817 shares during the period. 84.53% of the stock is currently owned by institutional investors.

Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) traded up 3.16% on Friday, reaching $55.48. The company’s stock had a trading volume of 995,807 shares. The stock has a 50 day moving average of $61.67 and a 200-day moving average of $56.55. The firm has a market cap of $2.94 billion, a price-to-earnings ratio of 18.56 and a beta of 1.31. Nu Skin Enterprises, Inc. has a 12 month low of $46.35 and a 12 month high of $66.04.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.69 by $0.08. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. The firm had revenue of $550.10 million for the quarter, compared to analysts’ expectations of $548.09 million. During the same period last year, the firm earned $0.79 earnings per share. The company’s revenue for the quarter was down 8.4% compared to the same quarter last year. On average, analysts anticipate that Nu Skin Enterprises, Inc. will post $3.23 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 13th. Stockholders of record on Friday, August 25th will be paid a dividend of $0.36 per share. The ex-dividend date of this dividend is Wednesday, August 23rd. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.60%. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 48.81%.

COPYRIGHT VIOLATION NOTICE: “Nu Skin Enterprises, Inc. (NUS) Shares Sold by Tudor Investment Corp ET AL” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/08/19/tudor-investment-corp-et-al-sells-6200-shares-of-nu-skin-enterprises-inc-nus-updated-updated-updated.html.

Several equities research analysts recently weighed in on NUS shares. Zacks Investment Research downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Saturday, May 6th. BidaskClub downgraded Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Deutsche Bank AG raised their price objective on Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a report on Wednesday, June 21st. Bank of America Corporation raised their price objective on Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a report on Monday, July 10th. Finally, Sidoti downgraded Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 target price on the stock. in a report on Wednesday, April 26th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $62.88.

In other news, General Counsel D Matthew Dorny sold 8,250 shares of the stock in a transaction dated Wednesday, July 5th. The shares were sold at an average price of $62.92, for a total transaction of $519,090.00. Following the completion of the sale, the general counsel now directly owns 46,730 shares in the company, valued at $2,940,251.60. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, President Ryan S. Napierski sold 8,000 shares of the stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $65.00, for a total transaction of $520,000.00. Following the sale, the president now owns 68,170 shares of the company’s stock, valued at $4,431,050. The disclosure for this sale can be found here. Insiders have sold 31,750 shares of company stock worth $1,946,810 over the last ninety days. Insiders own 5.20% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Stock Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related stocks with our FREE daily email newsletter.